An Ebola vaccine trial begins in DR Congo amid an outbreak of the Bundibugyo strain
The World Health Organization launched a new Ebola vaccine trial in the Democratic Republic of the Congo, where the outbreak surpassed 9,700 cases and has killed over 4,600 people. No vaccine is approved for the Bundibugyo strain, but scientists say science offers hope. The outbreak has spread across multiple African countries.
- The World Health Organisation announced a new Ebola vaccine trial in the Democratic Republic of the Congo.
- The trial will assess existing and experimental vaccines against the Bundibugyo strain.
- There is no approved vaccine for the Bundibugyo Ebola variant.
- More than 4600 people have died from Ebola since the outbreak was declared.
- The outbreak in the DRC has recorded more than 9,500 reported cases.
Outlets: Actualite.cd, Africanews, Berlingske, Channels TV, Daily Monitor (Uganda), Free Malaysia Today, Jamaica Observer, Le Monde.fr - Actualités et Infos en France et dans le monde, Observador, Poder360, Premium Times (Top), RTBF Info, RTP Notícias, Radio Okapi, The Citizen (Tanzania), The Hindu (International), The Independent (Uganda), Trouw, de Volkskrant
Written by AI from the outlets' reporting and checked automatically; it can contain mistakes. How Daily Brief works · Privacy